221 related articles for article (PubMed ID: 26956767)
1. The immunomodulatory properties of human bone marrow-derived mesenchymal stromal cells are defined according to multiple immunobiological criteria.
Fayyad-Kazan H; Faour WH; Badran B; Lagneaux L; Najar M
Inflamm Res; 2016 Jun; 65(6):501-10. PubMed ID: 26956767
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stromal cells from the foreskin: Tissue isolation, cell characterization and immunobiological properties.
Najar M; Raicevic G; André T; Fayyad-Kazan H; Pieters K; Bron D; Toungouz M; Lagneaux L
Cytotherapy; 2016 Mar; 18(3):320-35. PubMed ID: 26857227
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor.
Valencia J; Blanco B; Yáñez R; Vázquez M; Herrero Sánchez C; Fernández-García M; Rodríguez Serrano C; Pescador D; Blanco JF; Hernando-Rodríguez M; Sánchez-Guijo F; Lamana ML; Segovia JC; Vicente Á; Del Cañizo C; Zapata AG
Cytotherapy; 2016 Oct; 18(10):1297-311. PubMed ID: 27637760
[TBL] [Abstract][Full Text] [Related]
4. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory effects of mesenchymal stromal cells-derived exosome.
Chen W; Huang Y; Han J; Yu L; Li Y; Lu Z; Li H; Liu Z; Shi C; Duan F; Xiao Y
Immunol Res; 2016 Aug; 64(4):831-40. PubMed ID: 27115513
[TBL] [Abstract][Full Text] [Related]
6. Impact of different mesenchymal stromal cell types on T-cell activation, proliferation and migration.
Najar M; Raicevic G; Fayyad-Kazan H; De Bruyn C; Bron D; Toungouz M; Lagneaux L
Int Immunopharmacol; 2013 Apr; 15(4):693-702. PubMed ID: 23499510
[TBL] [Abstract][Full Text] [Related]
7. TGF-β1 Transduced Mesenchymal Stem Cells Have Profound Modulatory Effects on DCs and T Cells.
Daneshmandi S; Karimi MH; Pourfathollah AA
Iran J Immunol; 2017 Mar; 14(1):13-23. PubMed ID: 28341815
[TBL] [Abstract][Full Text] [Related]
8. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte inhibition is compromised in mesenchymal stem cells from psoriatic skin.
Liu R; Wang Y; Zhao X; Yang Y; Zhang K
Eur J Dermatol; 2014; 24(5):560-7. PubMed ID: 25445090
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal Stem Cells Upregulate the Expression of PD-L1 But Not VDR in Dendritic Cells.
Moravej A; Karimi MH; Geramizadeh B; Azarpira N; Zarnani AH; Yaghobi R; Khosravi M; Kalani M; Gharesi-Fard B
Immunol Invest; 2017 Jan; 46(1):80-96. PubMed ID: 27736253
[TBL] [Abstract][Full Text] [Related]
11. The Immunomodulatory Potential of Mesenchymal Stromal Cells: A Story of a Regulatory Network.
Najar M; Raicevic G; Crompot E; Fayyad-Kazan H; Bron D; Toungouz M; Lagneaux L
J Immunother; 2016; 39(2):45-59. PubMed ID: 26849074
[TBL] [Abstract][Full Text] [Related]
12. Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia.
Takam Kamga P; Bassi G; Cassaro A; Midolo M; Di Trapani M; Gatti A; Carusone R; Resci F; Perbellini O; Gottardi M; Bonifacio M; Nwabo Kamdje AH; Ambrosetti A; Krampera M
Oncotarget; 2016 Apr; 7(16):21713-27. PubMed ID: 26967055
[TBL] [Abstract][Full Text] [Related]
13. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells.
Gu YZ; Xue Q; Chen YJ; Yu GH; Qing MD; Shen Y; Wang MY; Shi Q; Zhang XG
Hum Immunol; 2013 Mar; 74(3):267-76. PubMed ID: 23261407
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
[TBL] [Abstract][Full Text] [Related]
15. Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes.
Zanone MM; Favaro E; Miceli I; Grassi G; Camussi E; Caorsi C; Amoroso A; Giovarelli M; Perin PC; Camussi G
J Clin Endocrinol Metab; 2010 Aug; 95(8):3788-97. PubMed ID: 20466784
[TBL] [Abstract][Full Text] [Related]
16. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.
Zimmermann JA; McDevitt TC
Cytotherapy; 2014 Mar; 16(3):331-45. PubMed ID: 24219905
[TBL] [Abstract][Full Text] [Related]
17. Human umbilical cord-derived mesenchymal stem cells suppress proliferation of PHA-activated lymphocytes in vitro by inducing CD4(+)CD25(high)CD45RA(+) regulatory T cell production and modulating cytokine secretion.
Yang H; Sun J; Li Y; Duan WM; Bi J; Qu T
Cell Immunol; 2016 Apr; 302():26-31. PubMed ID: 26774852
[TBL] [Abstract][Full Text] [Related]
18. Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes.
Najar M; Raicevic G; Jebbawi F; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Immunol Lett; 2012 Aug; 146(1-2):50-6. PubMed ID: 22575528
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory effects of umbilical cord-derived mesenchymal stem cells.
Shawki S; Gaafar T; Erfan H; El Khateeb E; El Sheikhah A; El Hawary R
Microbiol Immunol; 2015 Jun; 59(6):348-56. PubMed ID: 25869421
[TBL] [Abstract][Full Text] [Related]
20. Immunological modulation following bone marrow-derived mesenchymal stromal cells and Th17 lymphocyte co-cultures.
Najar M; Fayyad-Kazan H; Faour WH; Merimi M; Sokal EM; Lombard CA; Fahmi H
Inflamm Res; 2019 Mar; 68(3):203-213. PubMed ID: 30506263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
